Aesthetik Engi. (AESTHETIK)

Score breakdown: P/E: 2/3 · ROCE: 1/2 · Growth: 2/2 · Dividend: 0/1

Key Financials

Strengths

• Sales growth of 45.82% and profit growth of 422.39% indicate strong momentum
• PEG of 0.07 suggests the market is pricing in far lower growth than recent trends
• ROCE of 21.12% shows solid capital efficiency
• Promoter holding of 69.57% aligns management with shareholders
• Piotroski F-score of 7/9 points to generally sound financial health

Concerns

• Book value, ROE, and debt/equity are N/A, leaving balance-sheet quality and leverage unknown
• Zero dividend provides no income cushion for value investors
• Civil construction typically has low pricing power and intense competition
• Small market cap of ₹133 Cr can mean higher volatility and limited liquidity

AI Analysis

At first glance, this is exactly the kind of small-cap that demands caution: a civil construction company with a market cap of only ₹133 crore. But the numbers are interesting. The latest quarter shows sales of ₹38 crore and net profit of ₹4 crore, with a trailing P/E of 15.76. For a business growing sales 45.82% and profit 422.39%, that translates to a PEG of just 0.07—absurdly cheap if the growth is durable. However, profit grew far faster than sales, so I would ask whether margins are sustainable or simply a one-time boost. ROCE of 21.12% is respectable, and the Piotroski F-score of 7/9 suggests healthy fundamentals: improving profitability, efficiency, and no obvious red flags in the common financial signals. Promoter holding at 69.57% aligns their interests with mine, though it also means low public float and possible illiquidity. Still, there are many voids. Book value, ROE, and debt/equity are all not available—I cannot judge financial robustness or leverage. Zero dividend means my entire return depends on capital appreciation. Civil construction is not a wonderful business; it faces intense competition, cyclical demand, and project execution risk. With a 52-week range of ₹59.60 to ₹89.05, the current price is near the higher end, so there is no obvious Graham margin of safety based on disclosed balance-sheet data. I don't pay for growth unless the balance sheet confirms it. The growth metrics make this a fast grower, but the absence of critical data means I'd keep any position small and monitor quarterly order books, debt levels, and cash flow. If the growth continues and the balance sheet proves solid, this could merit deeper study. Until then, it is a promising but incomplete picture.

Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer